VLVbio is a Swedish biotechnology company located in Nacka, Stockholm and was established in 2013. We manufacture, R&D, and sell the PEVIVA products.
Better tools for more accurate detection of liver damage - that is VLVbio's mission. That is why we present our M30 and M65 ELISA assays, measuring apoptosis and total cell death by quantification of caspase-cleaved and total keratin 18, respectively. That is why we are aiming at setting new industry standards for the identification of liver injury and tumor control.
Our products are CE-marked and are used in the fields of hepatology, oncology, and toxicology.
The dead cells still count!
Company Details
- Employees
- 9
- Founded
- -
- Address
- Hästholmsvägen, 32, Nacka,13130,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- peviva.com
- Keywords
- Liver diseases (NAFLD, NASH, DILI, ASH, viral infections), Hepatoxicity, Oncology, Cell death, Apoptosis, Necrosis, Keratin 18 (K18), Toxicology.
- HQ
- Nacka
Vlvbio Questions
Vlvbio's website is peviva.com
Vlvbio's LinkedIn profile is https://se.linkedin.com/company/vlvbio
Vlvbio has
9 employees.
View email and phone details for 9
employees at Vlvbio.
Vlvbio's industry is
Biotechnology Research
Vlvbio's top competitors are
Eribis Pharmaceuticals,
Idl Diagnostics Ab (Idldx),
Mccartney Foundation,
Qiagen,
Emcura Ab,
Innate Pharmaceuticals Ab,
Boehringer Ingelheim,
Belach Bioteknik Ab,
Biotech-Igg,
Ipsen.
Vlvbio's categories are Biotechnology Research
Vlvbio's founding year is 2013
